Publicaciones en colaboración con investigadores/as de University of Manchester (2)

2023

  1. Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study

    BMJ open, Vol. 13, Núm. 7, pp. e075197

2021

  1. Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 1, pp. 60-71